CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | – | 13,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $1,805,000 | 0.60% |
| RA Capital Management | 6,991,003 | $21,113,000 | 0.46% |
| Ikarian Capital, LLC | 677,859 | $2,047,000 | 0.27% |
| Kynam Capital Management, LP | 227,759 | $688,000 | 0.22% |
| Octagon Capital Advisors LP | 279,921 | $845,000 | 0.18% |
| RTW INVESTMENTS, LP | 446,564 | $1,349,000 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,437,500 | $4,341,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 77,851 | $235,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 1,599,826 | $4,807,000 | 0.00% |
| CSS LLC/IL | 20,000 | $60,000 | 0.00% |